Novel usage of everolimus-eluting coronary stent for intracranial atherosclerotic disease: a technical report and case series.
Nangorgo Jean Oumar CoulibalyGriffin L ErnstHussain ShallwaniBeau HawkinsUsman BaberHakeem J ShakirPublished in: BMJ surgery, interventions, & health technologies (2023)
Second-generation EES such as Xience Skypoint may be utilized for treatment of medically-refractory ICAD. This technical report serves as a proof of concept for further studies analysing long-term safety and efficacy of such stents for treatment of ICAD.